top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
HPLC for pharmaceutical scientists [[electronic resource] /] / edited by Yuri Kazakevich, Rosario LoBrutto
HPLC for pharmaceutical scientists [[electronic resource] /] / edited by Yuri Kazakevich, Rosario LoBrutto
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2007
Descrizione fisica 1 online resource (1136 p.)
Disciplina 615.19
615.1901
615/.1901
Altri autori (Persone) KazakevichYuri
LoBruttoRosario
Soggetto topico High performance liquid chromatography
Drugs - Analysis
Clinical chemistry
ISBN 1-280-72166-9
9786610721665
0-470-08795-1
0-470-08794-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto HPLC FOR PHARMACEUTICAL SCIENTISTS; CONTENTS; PREFACE; CONTRIBUTORS; PART I HPLC THEORY AND PRACTICE; 1 Introduction; 1.1 Chromatography in the Pharmaceutical World; 1.2 Chromatographic Process; 1.3 Classification; 1.4 History of Discovery and Early Development (1903-1933); 1.5 General Separation Process; 1.5.1 Modern HPLC Column; 1.5.2 HPLC System; 1.6 Types of HPLC; 1.6.1 Normal-Phase Chromatography (NP HPLC); 1.6.2 Reversed-Phase HPLC (RP HPLC or RPLC); 1.6.3 Ion-Exchange Chromatography (IEX); 1.6.4 Size-Exclusion Chromatography (SEC); 1.7 HPLC Descriptors (Vr, k, N, etc.)
1.7.1 Retention Volume1.7.2 Void Volume; 1.7.3 Retention Factor; 1.7.4 Selectivity; 1.7.5 Efficiency; 1.7.6 Resolution; References; 2 HPLC Theory; 2.1 Introduction; 2.2 Basic Chromatographic Descriptors; 2.3 Efficiency; 2.4 Resolution; 2.5 HPLC Retention; 2.6 Retention Mechanism; 2.7 General Column Mass Balance; 2.8 Partitioning Model; 2.9 Adsorption Model; 2.10 Total and Excess Adsorption; 2.11 Mass Balance in Adsorption Model; 2.12 Adsorption of the Eluent Components; 2.13 Void Volume Considerations; 2.14 Thermodynamic Relationships; 2.14.1 Effect of the Eluent Composition
2.15 Adsorption-Partitioning Retention Mechanism2.16 Secondary Equilibria; 2.16.1 Inclusion of Secondary Equilibria in the Mass Balance; 2.16.2 Salt Effect; 2.17 Gradient Elution Principles; 2.18 Types of Analyte Interactions with the Stationary Phase; 2.19 Conclusion; References; 3 Stationary Phases; 3.1 Introduction; 3.2 Type of Packing Material (Porous, Nonporous, Monolithic); 3.3 Base Material (Silica, Zirconia, Alumina, Polymers); 3.4 Geometry; 3.4.1 Shape (Spherical/Irregular); 3.4.2 Particle Size Distribution; 3.4.3 Surface Area; 3.4.4 Pore Volume; 3.4.5 Surface Geometry
3.5 Adsorbent Surface Chemistry3.5.1 Surface Chemistry of the Base Material; 3.5.2 Silica; 3.5.3 Silica Hybrid; 3.5.4 Polymeric Packings; 3.5.5 Zirconia (Metal Oxides); 3.5.6 Porous Carbon (or Carbon-Coated Phases); 3.6 Surface of Chemically Modified Material; 3.6.1 Limits of Surface Modification; 3.6.2 Chemical Modification; 3.6.3 Types of Bonded Phases; 3.6.4 Structure of the Bonded Layer; 3.6.5 Density of Bonded Ligands; 3.6.6 Residual Silanoles; 3.6.7 Surface Area of Modified Adsorbent; 3.7 Polymer-Based Adsorbents; 3.8 Stationary Phases for Chiral Separations
3.8.1 Polysaccharide-Coated Phases3.8.2 Pirkle-Type Phases; 3.8.3 Protein Phases; 3.8.4 Molecular Imprinted Polymers for Chiral Separations; 3.9 Columns; 3.9.1 Capillary/Monolithic/Packed Columns; 3.9.2 Column Cleaning; 3.9.3 Column Void Volume; 3.9.4 Mass of Adsorbent in the Column; References; 4 Reversed-Phase HPLC; 4.1 Introduction; 4.2 Retention in Reversed-Phase HPLC; 4.3 Stationary Phases for RPLC; 4.4 Mobile Phases for RPLC; 4.4.1 Eluent Composition and Solvent Strength of the Mobile Phase; 4.4.2 Type of Organic Modifier
4.4.3 Selectivity as a Function of Type and Concentration of Organic Composition
Record Nr. UNINA-9910840886503321
Hoboken, N.J., : Wiley-Interscience, c2007
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
HPLC methods for recently approved pharmaceuticals / / George Lunn
HPLC methods for recently approved pharmaceuticals / / George Lunn
Autore Lunn George
Pubbl/distr/stampa Hoboken, N.J. : , : Wiley-Interscience, , 2005
Descrizione fisica 1 online resource (xxiii, 717 pages) : illustrations
Disciplina 615/.1
Soggetto topico High performance liquid chromatography
Drugs - Analysis
ISBN 1-280-27539-1
9786610275397
0-470-36038-0
0-471-71168-3
0-471-71167-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto HPLC METHODS FOR RECENTLY APPROVED PHARMACEUTICALS; CONTENTS; Preface; Acknowledgements; About This Book; Abacavir; Acarbose; Acetyl sulfisoxazole; Acrivastine; Adapalene; Adefovir dipivoxil; Adrenocorticotropic hormone; Afloqualone; Alacepril; Alclometasone 17,21-dipropionate; Alitretinoin; Allethrin; Almotriptan; Alosetron; Amcinonide; Aminolevulinic acid; Amprenavir; Anagrelide; Anakinra; Apraclonidine; Aprepitant; Aranidipine; Arotinolol; Arteether; Articaine; Asparaginase; Atazanavir sulfate; Atipamezole; Atomoxetine hydrochloride; Atorvastatin; Atosiban; Balofloxacin; Bambermycins
Befunolol; Benzalkonium chloride; Betaine; Bethanechol chloride; Bexarotene; Biapenem; Bimatoprost; Bioresmethrin; Bivalirudin; Boldenone; Bosentan; β-Boswellic acid; Brimonidine; Bromfenac; Brovincamine; Bucillamine; Budipine; Bulaquine; Butacaine; Butamben; Butoconazole; Butyl flufenamate; Cambendazole; Candesartan cilexetil; Capecitabine; Casanthranol; Caspofungin; Castor oil; Cefbuperazone; Cefditoren; Cefoselis; Cefozopran; Cefuzonam; Celecoxib; Cerivastatin; Cetrorelix; Cetyl alcohol; Cevimeline hydrochloride; Chlorobutanol; Chloroprocaine; Chorionic gonadotropin; Cilnidipine
Cimetropium bromide; Cisatracurium besylate; Citric acid; Clioquinol; Clobetasol 17-propionate; Clopidogrel; Clopidol; Cloricromen; Clorsulon; Colistin; Cypermethrin; Dalfopristin; Dalteparin; Daptomycin; Deferiprone; Deflazacort; Desloratadine; Desogestrel; Desoximetasone; Desoxycorticosterone; Dexrazoxane; Dextran; Diacerein; Dichloroacetic acid; Dichlorophen; Diclazuril; Dihydrotachysterol; Dimethyl sulfoxide; Dinitolmide; Dipivefrin; Dithiazanine iodide; Docarpamine; Dofetilide; Dolasetron; Donepezil; Doxefazepam; Doxercalciferol; Dropropizine; Drospirenone; Droxicam; Droxidopa; Ebrotidine
Edaravone; EDTA; Efavirenz; Efrotomycin; Egualen; Eletriptan; Emtricitabine; Enoxaparin sodium; Entacapone; Eperisone; Eplerenone; Epoprostenol; Eprosartan; Eptazocine; Eptifibatide; Erdosteine; Ergotamine; Ertapenem; Ethopabate; Ethyl icosapentate; Etonogestrel; Etoricoxib; Etorphine; Exemestane; Ezetimibe; Fadrozole; Falecalcitriol; Fenoxycarb; Fenticonazole; Fexofenadine; Flomoxef; Florfenicol; Fludrocortisone; Fluprostenol; Flurandrenolide; Flurithromycin; Flurogestone acetate; Fluticasone propionate; Flutrimazole; Fomepizole; Fomivirsen; Fondaparinux; Formestane; Formoterol
Fosamprenavir calcium; Fosinopril; Fosphenytoin; Frovatriptan; Fumagillin; Galantamine; Ganirelix; Gatifloxacin; Gefitinib; Gemcitabine; Gemifloxacin; Gestodene; Gestrinone; Glycerin; Guanabenz; Guanadrel; Halobetasol propionate; Halofuginone; Hetastarch; Hydroquinone; Hygromycin B; Iloprost; Imatinib; Imidocarb; Iobenguane; Iodixanol; Iopanoic acid; Iopromide; Ioversol; Ipratropium bromide; Ipriflavone; Isoflupredone; Isopropamide iodide; Itopride; Kinetin; Lafutidine; Lamivudine; Latanoprost; Leflunomide; Lercanidipine; Letrozole; Levetiracetam; Levonordefrin; Levosimendan; Lidamidine; Lincomycin
Record Nr. UNINA-9910143574003321
Lunn George  
Hoboken, N.J. : , : Wiley-Interscience, , 2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
HPLC methods for recently approved pharmaceuticals / / George Lunn
HPLC methods for recently approved pharmaceuticals / / George Lunn
Autore Lunn George
Edizione [1st ed.]
Pubbl/distr/stampa Hoboken, N.J. : , : Wiley-Interscience, , 2005
Descrizione fisica 1 online resource (xxiii, 717 pages) : illustrations
Disciplina 615/.1
Soggetto topico High performance liquid chromatography
Drugs - Analysis
ISBN 1-280-27539-1
9786610275397
0-470-36038-0
0-471-71168-3
0-471-71167-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto HPLC METHODS FOR RECENTLY APPROVED PHARMACEUTICALS; CONTENTS; Preface; Acknowledgements; About This Book; Abacavir; Acarbose; Acetyl sulfisoxazole; Acrivastine; Adapalene; Adefovir dipivoxil; Adrenocorticotropic hormone; Afloqualone; Alacepril; Alclometasone 17,21-dipropionate; Alitretinoin; Allethrin; Almotriptan; Alosetron; Amcinonide; Aminolevulinic acid; Amprenavir; Anagrelide; Anakinra; Apraclonidine; Aprepitant; Aranidipine; Arotinolol; Arteether; Articaine; Asparaginase; Atazanavir sulfate; Atipamezole; Atomoxetine hydrochloride; Atorvastatin; Atosiban; Balofloxacin; Bambermycins
Befunolol; Benzalkonium chloride; Betaine; Bethanechol chloride; Bexarotene; Biapenem; Bimatoprost; Bioresmethrin; Bivalirudin; Boldenone; Bosentan; β-Boswellic acid; Brimonidine; Bromfenac; Brovincamine; Bucillamine; Budipine; Bulaquine; Butacaine; Butamben; Butoconazole; Butyl flufenamate; Cambendazole; Candesartan cilexetil; Capecitabine; Casanthranol; Caspofungin; Castor oil; Cefbuperazone; Cefditoren; Cefoselis; Cefozopran; Cefuzonam; Celecoxib; Cerivastatin; Cetrorelix; Cetyl alcohol; Cevimeline hydrochloride; Chlorobutanol; Chloroprocaine; Chorionic gonadotropin; Cilnidipine
Cimetropium bromide; Cisatracurium besylate; Citric acid; Clioquinol; Clobetasol 17-propionate; Clopidogrel; Clopidol; Cloricromen; Clorsulon; Colistin; Cypermethrin; Dalfopristin; Dalteparin; Daptomycin; Deferiprone; Deflazacort; Desloratadine; Desogestrel; Desoximetasone; Desoxycorticosterone; Dexrazoxane; Dextran; Diacerein; Dichloroacetic acid; Dichlorophen; Diclazuril; Dihydrotachysterol; Dimethyl sulfoxide; Dinitolmide; Dipivefrin; Dithiazanine iodide; Docarpamine; Dofetilide; Dolasetron; Donepezil; Doxefazepam; Doxercalciferol; Dropropizine; Drospirenone; Droxicam; Droxidopa; Ebrotidine
Edaravone; EDTA; Efavirenz; Efrotomycin; Egualen; Eletriptan; Emtricitabine; Enoxaparin sodium; Entacapone; Eperisone; Eplerenone; Epoprostenol; Eprosartan; Eptazocine; Eptifibatide; Erdosteine; Ergotamine; Ertapenem; Ethopabate; Ethyl icosapentate; Etonogestrel; Etoricoxib; Etorphine; Exemestane; Ezetimibe; Fadrozole; Falecalcitriol; Fenoxycarb; Fenticonazole; Fexofenadine; Flomoxef; Florfenicol; Fludrocortisone; Fluprostenol; Flurandrenolide; Flurithromycin; Flurogestone acetate; Fluticasone propionate; Flutrimazole; Fomepizole; Fomivirsen; Fondaparinux; Formestane; Formoterol
Fosamprenavir calcium; Fosinopril; Fosphenytoin; Frovatriptan; Fumagillin; Galantamine; Ganirelix; Gatifloxacin; Gefitinib; Gemcitabine; Gemifloxacin; Gestodene; Gestrinone; Glycerin; Guanabenz; Guanadrel; Halobetasol propionate; Halofuginone; Hetastarch; Hydroquinone; Hygromycin B; Iloprost; Imatinib; Imidocarb; Iobenguane; Iodixanol; Iopanoic acid; Iopromide; Ioversol; Ipratropium bromide; Ipriflavone; Isoflupredone; Isopropamide iodide; Itopride; Kinetin; Lafutidine; Lamivudine; Latanoprost; Leflunomide; Lercanidipine; Letrozole; Levetiracetam; Levonordefrin; Levosimendan; Lidamidine; Lincomycin
Record Nr. UNINA-9910815909103321
Lunn George  
Hoboken, N.J. : , : Wiley-Interscience, , 2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
HPLC methods for recently approved pharmaceuticals / George Lunn
HPLC methods for recently approved pharmaceuticals / George Lunn
Autore Lunn, George
Pubbl/distr/stampa Hoboken, N.J. : Wiley-Interscience, 2005
Descrizione fisica xxiii, 717 p. : ill. ; 26 cm
Disciplina 615.1
Soggetto topico High performance liquid chromatography
Drugs - Analysis
ISBN 0471669415
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNISALENTO-991000490619707536
Lunn, George  
Hoboken, N.J. : Wiley-Interscience, 2005
Materiale a stampa
Lo trovi qui: Univ. del Salento
Opac: Controlla la disponibilità qui
Integrated strategies for drug discovery using mass spectrometry [[electronic resource] /] / [edited by] Mike S. Lee
Integrated strategies for drug discovery using mass spectrometry [[electronic resource] /] / [edited by] Mike S. Lee
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2005
Descrizione fisica 1 online resource (570 p.)
Disciplina 615.19
615/.19
Altri autori (Persone) LeeMike S. <1960->
Collana Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods
Soggetto topico Mass spectrometry
Drugs - Analysis
High throughput screening (Drug development)
ISBN 1-280-27658-4
9786610276585
0-470-24248-5
0-471-72103-4
0-471-72102-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Miniaturized formats for efficient liquid chromatography mass spectrometry-based proteomics and therapeutic development / Gary A. Valaskovic -- Mass spectrometry based drug screening assays for early phases in drug discovery / Marshall M. Siegel -- ESI-FTICR as a high throughput drug discovery platform / Kristin A. Sannes-Lowery -- Mass spectrometry based proteomic approaches for disease diagnosis and biomarker discovery / Thomas P. Conrads -- Metabonomic applications in toxicity screening and disease diagnosis / John P. Shockcor -- The central role of mass spectrometry in natural products discovery / Jeffrey R. Gilbert -- Application of mass spectrometry to compound library generation, analysis, and management / Xueheng Cheng -- A Combinatorial process for drug discovery / David S. Wagner -- Application of technological advances in biotransformation studies / Carmen L. Fernandez-Metzler -- Applications of mass spectrometry for the characterization of reactive metabolites of drugs in discovery / Jim Wang -- Advances in high-throughput quantitative drug discovery bioanalysis / Bradley L. Ackermann -- New strategies for the implementation and support of bioanalysis in a drug metabolism environment / Walter A. Korfmacher -- An integrated LC/MS strategy for preclinical candidate optimization / Jonathan L. Josephs -- New approaches for method development and purification in lead optimization / Yining Zhao -- High throughput metabolic and physicochemical property analysis / Edward H. Kerns -- Organ perfusion and mass spectrometry / C. Gerald Curtis -- Sample preparation for drug discovery bioanalysis / David A. Wells -- Automation / John D. Laycock.
Record Nr. UNINA-9910143579703321
Hoboken, N.J., : Wiley-Interscience, c2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrated strategies for drug discovery using mass spectrometry [[electronic resource] /] / [edited by] Mike S. Lee
Integrated strategies for drug discovery using mass spectrometry [[electronic resource] /] / [edited by] Mike S. Lee
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2005
Descrizione fisica 1 online resource (570 p.)
Disciplina 615.19
615/.19
Altri autori (Persone) LeeMike S. <1960->
Collana Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods
Soggetto topico Mass spectrometry
Drugs - Analysis
High throughput screening (Drug development)
ISBN 1-280-27658-4
9786610276585
0-470-24248-5
0-471-72103-4
0-471-72102-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Miniaturized formats for efficient liquid chromatography mass spectrometry-based proteomics and therapeutic development / Gary A. Valaskovic -- Mass spectrometry based drug screening assays for early phases in drug discovery / Marshall M. Siegel -- ESI-FTICR as a high throughput drug discovery platform / Kristin A. Sannes-Lowery -- Mass spectrometry based proteomic approaches for disease diagnosis and biomarker discovery / Thomas P. Conrads -- Metabonomic applications in toxicity screening and disease diagnosis / John P. Shockcor -- The central role of mass spectrometry in natural products discovery / Jeffrey R. Gilbert -- Application of mass spectrometry to compound library generation, analysis, and management / Xueheng Cheng -- A Combinatorial process for drug discovery / David S. Wagner -- Application of technological advances in biotransformation studies / Carmen L. Fernandez-Metzler -- Applications of mass spectrometry for the characterization of reactive metabolites of drugs in discovery / Jim Wang -- Advances in high-throughput quantitative drug discovery bioanalysis / Bradley L. Ackermann -- New strategies for the implementation and support of bioanalysis in a drug metabolism environment / Walter A. Korfmacher -- An integrated LC/MS strategy for preclinical candidate optimization / Jonathan L. Josephs -- New approaches for method development and purification in lead optimization / Yining Zhao -- High throughput metabolic and physicochemical property analysis / Edward H. Kerns -- Organ perfusion and mass spectrometry / C. Gerald Curtis -- Sample preparation for drug discovery bioanalysis / David A. Wells -- Automation / John D. Laycock.
Record Nr. UNINA-9910830715203321
Hoboken, N.J., : Wiley-Interscience, c2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrated strategies for drug discovery using mass spectrometry [[electronic resource] /] / [edited by] Mike S. Lee
Integrated strategies for drug discovery using mass spectrometry [[electronic resource] /] / [edited by] Mike S. Lee
Pubbl/distr/stampa Hoboken, N.J., : Wiley-Interscience, c2005
Descrizione fisica 1 online resource (570 p.)
Disciplina 615.19
615/.19
Altri autori (Persone) LeeMike S. <1960->
Collana Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods
Soggetto topico Mass spectrometry
Drugs - Analysis
High throughput screening (Drug development)
ISBN 1-280-27658-4
9786610276585
0-470-24248-5
0-471-72103-4
0-471-72102-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Miniaturized formats for efficient liquid chromatography mass spectrometry-based proteomics and therapeutic development / Gary A. Valaskovic -- Mass spectrometry based drug screening assays for early phases in drug discovery / Marshall M. Siegel -- ESI-FTICR as a high throughput drug discovery platform / Kristin A. Sannes-Lowery -- Mass spectrometry based proteomic approaches for disease diagnosis and biomarker discovery / Thomas P. Conrads -- Metabonomic applications in toxicity screening and disease diagnosis / John P. Shockcor -- The central role of mass spectrometry in natural products discovery / Jeffrey R. Gilbert -- Application of mass spectrometry to compound library generation, analysis, and management / Xueheng Cheng -- A Combinatorial process for drug discovery / David S. Wagner -- Application of technological advances in biotransformation studies / Carmen L. Fernandez-Metzler -- Applications of mass spectrometry for the characterization of reactive metabolites of drugs in discovery / Jim Wang -- Advances in high-throughput quantitative drug discovery bioanalysis / Bradley L. Ackermann -- New strategies for the implementation and support of bioanalysis in a drug metabolism environment / Walter A. Korfmacher -- An integrated LC/MS strategy for preclinical candidate optimization / Jonathan L. Josephs -- New approaches for method development and purification in lead optimization / Yining Zhao -- High throughput metabolic and physicochemical property analysis / Edward H. Kerns -- Organ perfusion and mass spectrometry / C. Gerald Curtis -- Sample preparation for drug discovery bioanalysis / David A. Wells -- Automation / John D. Laycock.
Record Nr. UNINA-9910841232003321
Hoboken, N.J., : Wiley-Interscience, c2005
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Interpretation of MS-MS mass spectra of drugs and pesticides / / Wilfried M. A. Niessen, Ricardo A. Correa C
Interpretation of MS-MS mass spectra of drugs and pesticides / / Wilfried M. A. Niessen, Ricardo A. Correa C
Autore Niessen W. M. A (Wilfried M. A.), <1956->
Pubbl/distr/stampa Hoboken, New Jersey : , : Wiley, , 2017
Descrizione fisica 1 online resource (412 pages) : illustrations, tables
Disciplina 543/.65
Collana Wiley Series on Mass Spectrometry
Soggetto topico Tandem mass spectrometry
Liquid chromatography
Drugs - Analysis
Pesticides - Analysis
ISBN 1-119-29424-X
1-119-29426-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction to LC-MS technology -- Interpretation of mass spectra -- Fragmentation of even-electron ions -- Fragmentation of drugs and pesticides -- Identification strategies.
Record Nr. UNINA-9910158598203321
Niessen W. M. A (Wilfried M. A.), <1956->  
Hoboken, New Jersey : , : Wiley, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Interpretation of MS-MS mass spectra of drugs and pesticides / / Wilfried M. A. Niessen, Ricardo A. Correa C
Interpretation of MS-MS mass spectra of drugs and pesticides / / Wilfried M. A. Niessen, Ricardo A. Correa C
Autore Niessen W. M. A (Wilfried M. A.), <1956->
Pubbl/distr/stampa Hoboken, New Jersey : , : Wiley, , 2017
Descrizione fisica 1 online resource (412 pages) : illustrations, tables
Disciplina 543/.65
Collana Wiley Series on Mass Spectrometry
Soggetto topico Tandem mass spectrometry
Liquid chromatography
Drugs - Analysis
Pesticides - Analysis
ISBN 1-119-29424-X
1-119-29426-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction to LC-MS technology -- Interpretation of mass spectra -- Fragmentation of even-electron ions -- Fragmentation of drugs and pesticides -- Identification strategies.
Record Nr. UNINA-9910822184903321
Niessen W. M. A (Wilfried M. A.), <1956->  
Hoboken, New Jersey : , : Wiley, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Introduction to Pharmaceutical Chemical Analysis
Introduction to Pharmaceutical Chemical Analysis
Autore Hansen Steen
Pubbl/distr/stampa Hoboken, : Wiley, 2011
Descrizione fisica 1 online resource (512 p.)
Disciplina 615.19
Altri autori (Persone) Pedersen-BjergaardStig
RasmussenKnut
Soggetto topico Drugs - Analysis
Pharmaceutical chemistry
ISBN 1-283-30679-4
9786613306791
1-119-95364-2
1-119-95360-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction to Pharmaceutical Chemical Analysis; Table of Contents; Preface; 1 Introduction to Pharmaceutical Analysis; 1.1 Applications and Definitions; 1.2 The Life of Medicines; 1.3 The Quality of Medical Products; 1.4 Summary; 2 International Pharmacopoeias, Regulations and Guidelines; 2.1 Overview of Legislation; 2.2 Legislation and Regulations for Industrial Production; 2.3 Life Time of Drugs and Drug Substances; 2.4 Pharmacopoeias; 2.5 International Harmonization; 2.5.1 International Conference on Harmonization; 2.5.2 Pharmacopoeial Discussion Group
2.6 Legislation and Regulations for Pharmacy Production2.7 Summary; 3 Fundamental Chemical Properties, Buffers and pH; 3.1 pH and pKa; 3.2 Partition; 3.3 Stereochemistry; 3.4 Stability Testing; 3.5 Summary; 4 Fundamentals of Pharmaceutical Analysis; 4.1 What is a Pharmaceutical (Chemical) Analysis?; 4.2 How to Specify Quantities and Concentrations?; 4.3 Basic Laboratory Equipment; 4.3.1 The Analytical Balance; 4.3.2 Pipettes; 4.3.3 Volumetric Flasks; 4.3.4 Burettes; 4.4 How to Make Solutions and Dilutions; 4.5 Calibration of Analytical Methods; 4.6 Errors, Accuracy, and Precision
4.6.1 Systematic and Random Errors4.6.2 Accuracy and Precision; 4.7 Statistics; 4.7.1 Mean Value and Standard Deviation; 4.7.2 Confidence Intervals; 4.7.3 Comparison of Means with a t-Test; 4.7.4 Q-Test to Reject Outliers; 4.7.5 Linear Regression with the Method of Least Squares; 4.7.6 How to Present an Analytical Result; 4.8 Some Words and Concepts; 4.8.1 Analysis and Determination; 4.8.2 Sample Replicates and Measuring Replicates; 4.8.3 Interference; 4.8.4 Blind Samples; 5 Titrimetric Methods; 5.1 Introduction; 5.2 Acid-Base Titrations; 5.3 Acid-Base Titrations in Non-Aqueous Media
5.4 Redox Titrations5.5 Other Principles of Titration; 5.6 Summary; 6 Introduction to Spectroscopic Methods; 6.1 Electromagnetic Radiation; 6.2 Molecules and Electromagnetic Radiation; 6.3 Atoms and Electromagnetic Radiation; 6.4 Summary; 7 UV Spectrophotometry; 7.1 Principle of Quantitative Determination; 7.2 Principle of Identification; 7.3 Which Substances Have Strong UV Absorbance?; 7.4 Instrumentation; 7.5 Practical Work and Method Development; 7.6 Areas of Usage and Performance; 7.7 System Testing; 7.8 Summary; 8 IR Spectrophotometry; 8.1 IR Spectrophotometry; 8.2 Instrumentation
8.3 Scope8.4 Instrument Calibration; 8.5 NIR Spectrophotometry; 8.6 Applications; 8.7 Summary; 9 Atomic Spectrometry; 9.1 Atomic Absorption Spectrometry; 9.2 Instrumentation; 9.3 Applications and Performance; 9.4 Practical Work and Method Development; 9.5 Atomic Emission Spectrometry; 9.6 Instrumentation; 9.7 Summary; 10 Chromatography; 10.1 General Principles; 10.2 Retention; 10.3 Column Efficiency; 10.4 Selectivity; 10.5 Peak Symmetry; 10.6 Resolution; 10.7 Chromatographic Techniques; 10.8 Summary; 11 Chromatographic Separation Principles; 11.1 General Introduction
11.2 Normal Phase Chromatography
Record Nr. UNINA-9910139569303321
Hansen Steen  
Hoboken, : Wiley, 2011
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui